Luke Elizabeth Hanna Selected Research

Luke Elizabeth Hanna Research Topics

Disease

14	Tuberculosis (Tuberculoses) 01/2022 - 12/2005
12	Infections 07/2021 - 12/2005
9	HIV Infections (HIV Infection) 10/2021 - 10/2012
3	Inflammation (Inflammations) 11/2022 - 01/2019
3	Pulmonary Tuberculosis 01/2018 - 12/2005
2	Latent Tuberculosis 01/2022 - 01/2018
2	COVID-19 07/2021 - 04/2021
2	Disease Progression 01/2018 - 12/2005
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021
1	COVID-19 related pediatric multisystem inflammatory disease 04/2021
1	Cytokine Release Syndrome 04/2021
1	Coinfection 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2019
1	Cicatrix (Scar) 01/2018
1	Extensively Drug-Resistant Tuberculosis 04/2016
1	Lymph Node Tuberculosis (Scrofula) 09/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2012
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 03/2012
1	Malaria 07/2008
1	Leprosy (Hansen's Disease) 07/2008
1	Rheumatoid Arthritis 07/2008

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
6	Pharmaceutical PreparationsIBA 04/2020 - 03/2012
5	CytokinesIBA 04/2021 - 12/2005
3	EpitopesIBA 11/2020 - 10/2012
3	Isoniazid (Ftivazide)FDA LinkGeneric 04/2020 - 11/2016
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2020 - 01/2016
2	LipidsIBA 01/2022 - 09/2019
2	Lipopolysaccharide ReceptorsIBA 07/2021 - 01/2019
2	Interleukin-10 (Interleukin 10)IBA 04/2021 - 01/2018
2	Broadly Neutralizing AntibodiesIBA 01/2019 - 01/2018
2	Monoclonal AntibodiesIBA 01/2018 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 10/2015 - 08/2012
1	Antiviral Agents (Antivirals)IBA 10/2021
1	Immunologic Factors (Immunomodulators)IBA 10/2021
1	C-Reactive ProteinIBA 07/2021
1	lipopolysaccharide-binding proteinIBA 07/2021
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 07/2021
1	Amyloid (Amyloid Fibrils)IBA 07/2021
1	HaptoglobinsIBA 07/2021
1	LipopolysaccharidesIBA 07/2021
1	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 07/2021
1	SodiumIBA 04/2021
1	Interleukin-2 (IL2)IBA 04/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2021
1	Interleukin-6 (Interleukin 6)IBA 04/2021
1	Granzymes (Granzyme)IBA 04/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021
1	Interleukin-17 (Interleukin 17)IBA 04/2021
1	Interleukin-15 (Interleukin 15)IBA 04/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2021
1	Interleukin-33IBA 04/2021
1	VaccinesIBA 12/2020
1	Glycoproteins (Glycoprotein)IBA 11/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2020
1	Amino Acids FDA Link 09/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 09/2019
1	Lipoproteins (Lipoprotein)IBA 09/2019
1	Lamivudine (Epivir)FDA Link 01/2019
1	Zidovudine (Retrovir)FDA LinkGeneric 01/2019
1	Anti-HIV Agents (AIDS Drugs)IBA 01/2019
1	Maraviroc FDA Link 01/2018
1	Tuberculin (PPD)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	GoldIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Neutralizing AntibodiesIBA 01/2018
1	AIDS VaccinesIBA 10/2017
1	Pyrazinamide FDA LinkGeneric 01/2017
1	tat Gene Products (tat Protein)IBA 01/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2014
1	HLA-B Antigens (HLA-B)IBA 10/2012
1	HLA-A*02:01 antigenIBA 10/2012
1	HLA-B*27:05 antigenIBA 10/2012
1	Peptides (Polypeptides)IBA 10/2012
1	AntigensIBA 08/2012
1	AntibodiesIBA 07/2008
1	HIV AntigensIBA 07/2008
1	Chemokine CCL3IBA 12/2005
1	Chemokine CCL4IBA 12/2005
1	Chemokine ReceptorsIBA 12/2005
1	ChemokinesIBA 12/2005
1	Chemokine CCL5IBA 12/2005
1	CC ChemokinesIBA 12/2005

Therapy/Procedure

3	Therapeutics 10/2021 - 01/2018
1	Highly Active Antiretroviral Therapy (HAART) 11/2022
1	Art Therapy 09/2019